ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,747 | +289.6% | 37,596 | 0.0% | 0.00% | – |
Q2 2023 | $12,256 | -24.2% | 37,596 | 0.0% | 0.00% | – |
Q1 2023 | $16,166 | -18.9% | 37,596 | 0.0% | 0.00% | – |
Q4 2022 | $19,926 | -28.8% | 37,596 | 0.0% | 0.00% | – |
Q3 2022 | $28,000 | -34.9% | 37,596 | 0.0% | 0.00% | – |
Q2 2022 | $43,000 | -18.9% | 37,596 | +107.8% | 0.00% | – |
Q4 2021 | $53,000 | -31.2% | 18,093 | 0.0% | 0.00% | – |
Q3 2021 | $77,000 | -19.8% | 18,093 | 0.0% | 0.00% | – |
Q2 2021 | $96,000 | -56.4% | 18,093 | -68.4% | 0.00% | – |
Q1 2020 | $220,000 | -36.6% | 57,333 | 0.0% | 0.00% | – |
Q4 2019 | $347,000 | -20.0% | 57,333 | 0.0% | 0.00% | – |
Q3 2019 | $434,000 | -39.2% | 57,333 | +8.8% | 0.00% | – |
Q2 2019 | $714,000 | +327.5% | 52,688 | +174.4% | 0.00% | – |
Q1 2018 | $167,000 | -30.7% | 19,200 | 0.0% | 0.00% | – |
Q4 2017 | $241,000 | +49.7% | 19,200 | 0.0% | 0.00% | – |
Q3 2017 | $161,000 | -50.6% | 19,200 | 0.0% | 0.00% | – |
Q2 2017 | $326,000 | – | 19,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
Founders Capital Management | 3,000 | $9,000 | 0.01% |
King Wealth Management Group | 16,000 | $33,000 | 0.01% |
Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |